Introduction
Depression affects people all over the world [1] . Patients with chronic diseases in general and those with chronic obstructive pulmonary disease (COPD) in particular are likely to have coexisting depression compared with healthy individuals. There is a higher incidence of depression in patients with more severe COPD. In Pakistan, the frequency of depression in COPD patients has been reported as 15% and 72% in two different studies, while in China, a neighboring country, the frequency of depression was reported to be 35.7% [2] [3] [4] .
Depression is also associated with frequent hospital readmission for acute exacerbation and is an independent prognostic factor for mortality in such patients [5, 6] . Functional impairments associated with COPD are themselves potential promoters of depressive morbidity and chronicity [7, 8] . Previous studies identified many factors associated with depression in COPD patients such as age, gender, employment status, living alone, and use of steroids [9] [10] [11] .
Diagnosis of depression in patients with COPD is important, as early intervention to manage depression may improve patient's quality of life and decrease the cost of management. This study aimed to estimate the frequency and risk factors of depression among patients with COPD.
Materials And Methods
This cross-sectional study was conducted on 556 COPD patients aged 40 or above, who were consecutively recruited from the Pulmonology Clinic of the Aga Khan University in Karachi, Pakistan, from March 2010 to March 2011. Patients with preexisting depression, those with a recent death (within six months) of a spouse, sibling, parent or a child, and those on oral steroids were excluded from the study.
After obtaining written informed consent, a structured pretested questionnaire was administered for data collection. The questionnaire was composed of two sections. The first section included the demographic information of the participants, and the second part included the Hospital Anxiety and Depression Scale (HADS) to screen for depression. HADS is a validated screening tool with a sensitivity of 70% and a specificity of 90% [12] . The score ranges from zero to 21 for each subscale. Those COPD patients with scores eight or higher were labeled as having depression [12] .
Descriptive, univariate, and multivariate logistic regression analyses were performed using SPSS Statistics for Windows, Version 19.0. (IBM Corp, Armonk, NY). Univariate analysis was carried out using simple logistic regression to evaluate each variable for its unadjusted association with depression by computing unadjusted odds ratios (ORs) and their 95% confidence intervals (CI). Multivariable analysis was done using multiple logistic regressions to identify factors associated with depression and was reported as adjusted odds ratio (ORadj) and their 95% confidence intervals. p < 0.05 was considered statistically significant throughout the analysis.
Results
A total of 556 of 650 patients consented to participate in the study resulting in a response rate of 85%. The demographic details of the study population are presented in Table 1 . Fifty-seven percent of the patients with COPD who participated in the study were depressed. 
Variables n Percentages Age
238 74.8 152 63.9 1 1 0.091 Female 80 25.2 86 36.1 1.683 (1.16-2.42) 2.13 (0.88-5.14) Educational
Discussion
In this study, 57.2% of patients with COPD also had depression. Two studies conducted in Pakistan reported the frequency of depression in patients with COPD to be 15% and 72%. The reason for this difference could be due to the small sample sizes used in those studies as compared to ours. Those studies also used different screening tools and were unable to control for confounding factors [2, 3] .
A case-control study conducted on Chinese patients with and without COPD reported that the prevalence of depression is 35.7% in patients with COPD compared to 7.2% in patients without COPD [4] . In India, 33.3% of patients with COPD showed moderate to severe depression, whereas 20.6% of patients had major depressive disorder [13] . The prevalence of depression in patients with COPD varies depending upon the country, study settings, and screening tools used.
Some studies state clinically significant levels of depression in patients with COPD were more prevalent in patients under age 60 [4, 8, 14] . This contrasts with our findings; we noted that patients with COPD over age 59 were more likely to have depression compared to patients aged 59 and younger. Depression in elderly COPD patients may reduce independence, resulting in a growing dependence on medical care. Similar findings have also been reported [15] .
Smokers with COPD were more likely to have depressive symptoms in our study, which is a similar finding in many other studies [8, 16, 17] .
Several studies reported gender is an insignificant determinant of depression in patients with COPD, others concluded the female gender has a significant association with depression in these patients [4, 8, 14, 16] . In contrast, our results showed male patients were more likely to suffer from depression. This may be due to a different study population in Pakistan where men are usually the family's main provider, and a chronic illness like COPD might cause a reduced ability to work, creating increased stress levels which can lead to depression. Further studies are needed to explore the association of the male gender and depression among patients with COPD.
We found that unemployment was directly associated with depression. Patients with COPD aged over 59 years were more likely to suffer from depression, and most of the patients over 59 years in our study were retired. A Turkish study also found similar results [9] . Living with the financial difficulties puts the retired COPD patients at a great social disadvantage and causes mental stresses and worries which then contributes toward the development of depression.
In our study, patients with COPD who lived alone were found to be at a higher risk of depression than those who have strong family support. These findings are consistent with a similar study conducted by Gudmundsson et al. on COPD and depression [10] . A possible explanation for this association of living alone and depression could be that patients living alone have fewer caregivers to provide physical and emotional support; this lack of support can contribute to depression. Interventions should be included to identify and strengthen the social networks of patients with COPD.
COPD patients on long-term steroid use reported a higher level of depression than those who were not receiving steroids. Gift et al. also found a strong association between depression in patients with COPD and steroid use [11] . Further studies are warranted to explore this relationship so that patients with COPD who also require steroid treatment can be monitored and treated accordingly.
Our study was limited in that participants of our study may not be representative of the general population; participants were subjects who attended a tertiary care hospital and may have different characteristics and severity levels than the general population. Moreover, this was a cross-sectional study, so temporality is difficult to establish, i.e., cause and effect relation between the factors and the disease (COPD).
Moreover, further studies are needed to determine the prevalence of depression in patients with COPD and to further investigate its causative factors in our society.
Conclusions
Our findings indicate a need to focus on depressive symptoms and risk factors associated with depression among patients with COPD. Families and communities should be made aware of depressive symptoms and its associated risk factors so that patients can be screened earlier.
Clinicians can support positive mental health outcomes through the early identification of patients with COPD who may be at risk for psychological distress. Clinicians could refer these patients for individual or group counseling in an effort to improve outcomes and quality of life for these patients.
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